| Direct inhibition of MmpL3 by novel antitubercular compounds W Li, CM Stevens, AN Pandya, Z Darzynkiewicz, P Bhattarai, W Tong, ... ACS infectious diseases 5 (6), 1001-1012, 2019 | 80 | 2019 |
| Transporters involved in the biogenesis and functionalization of the mycobacterial cell envelope M Jackson, CM Stevens, L Zhang, HI Zgurskaya, M Niederweis Chemical reviews 121 (9), 5124-5157, 2020 | 41 | 2020 |
| The MmpL3 interactome reveals a complex crosstalk between cell envelope biosynthesis and cell elongation and division in mycobacteria JM Belardinelli, CM Stevens, W Li, YZ Tan, V Jones, F Mancia, ... Scientific reports 9 (1), 10728, 2019 | 35 | 2019 |
| Proton transfer activity of the reconstituted Mycobacterium tuberculosis MmpL3 is modulated by substrate mimics and inhibitors CM Stevens, SO Babii, AN Pandya, W Li, Y Li, J Mehla, R Scott, P Hegde, ... Proceedings of the National Academy of Sciences 119 (30), e2113963119, 2022 | 10 | 2022 |
| Microbiological profile, preclinical pharmacokinetics and efficacy of CRS0393, a novel antimycobacterial agent targeting MmpL3 UA Ochsner, MA De Groote, TC Jarvis, H Liu, T Youmans, T Hoang, ... Tuberculosis 138, 102288, 2023 | 5 | 2023 |
| Structural determinants of indole-2-carboxamides: identification of lead acetamides with pan antimycobacterial activity P Bhattarai, P Hegde, W Li, PK Prathipati, CM Stevens, L Yang, H Zhou, ... Journal of medicinal chemistry 66 (1), 170-187, 2022 | 4 | 2022 |
| Purification, Mechanism, and Biochemical Interactions of the Essential Mycolic Acid Transporters MmpL3 from Mycobacterium tuberculosis, and CmpL1 from Corynebacterium glutamicum. C Stevens | | 2020 |
